Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

FCGR3A-158V/F Polymorphism May Correlate with the Levels of Immunoglobulin in Patients with Non-Hodgkin’s Lymphoma after Rituximab Treatment as An Adjuvant to Autologous Stem Cell Transplantation.

Mitsufumi Nishio, MD, PhD, Tomoyuki Endo, M.D., Ph.D., Katsuya Fujimoto, M.D., Ph.D., Satoshi Yamamoto, M.D., Ph.D., Masato Obara, M.D., Keisuke Yamaguchi, M.D., Yukari Takeda, M.D., Hideki Goto, M.D., Ikumi Kasahara, M.D., Norihiro Sato, M.D., Ph.D., Takao Koike, M.D., Ph.D.

Blood (2008) 112 (11): 3245.

https://doi.org/10.1182/blood.V112.11.3245.3245

Published: 2008

Journal Articles

DOCK180, a New Surrogate Marker to Distinguish CD34 Positive Acute Leukemia Cells from CD34 Positive Normal Hematopoietic Stem/Progenitor Cells.

Mitsufumi Nishio, MD, PhD, Kohki Kumano, M.D., Ph.D., Katsuya Fujimoto, M.D., Ph.D., Tomoyuki Endo, M.D., Ph.D., Satoshi Yamamoto, M.D., Ph.D., Akio Shigematsu, MD, PhD, Takeshi Kondo, MD., PhD, Junji Tanaka, MD, PhD, Satoshi Hashino, Masahiro Imamura, Hiroshi Nishihara, M.D., Ph.D., Norihiro Sato, M.D., Ph.D., Takao Koike, M.D., Ph.D.

Blood (2008) 112 (11): 1476.

https://doi.org/10.1182/blood.V112.11.1476.1476

Published: 2008

Journal Articles

Delayed Redistribution of CD27, CD40 and CD80 Positive B Cells and the Impaired In Vitro Immunoglobulin G Production in Patients with Non-Hodgkin Lymphoma Treated with Rituximab.

Mitsufumi Nishio, MD, PhD, Katsuya Fujimoto, MD, PhD, Satoshi Yamamoto, MD, PhD, Toshiya Sakai, MD, Kohki Kumano, MD, Masato Obara, MD, Kazuki Koizumi, MD, PhD, Masaya Mukai, MD, PhD, Norihiro Sato, MD, PhD, Takao Koike, MD, PhD

Blood (2006) 108 (11): 938.

https://doi.org/10.1182/blood.V108.11.938.938

Published: 2006

Journal Articles

Absence of an IgD−/CD27+ Switched Memory B Cell Population with Persistent Hypogammaglobulinemia after Rituximab Administration as an Adjuvant Therapy after Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma.

Mitsufumi Nishio, MD, PhD, Katsuya Fujimoto, MD, Satoshi Yamamoto, MD, PhD, Toshiya Sakai, MD, Masato Obara, MD, Koki Kumano, MD, Koichiro Minauchi, MD, Masayuki Yamakura, MD, Norihiro Sato, MD, PhD, Takao Koike, MD, PhD

Blood (2005) 106 (11): 1412.

https://doi.org/10.1182/blood.V106.11.1412.1412

Published: 2005

Journal Articles

A Clinical Trial of VVR Rate in Preoperative Autologous Blood Donation by Adults and Pediatrics Patients with or without IV Fluid Infusion.

Sumiko Kobayashi, M.D., Ph. D, Norihiro Sato, M.D., Ph.D, Satoshi Hashino, M.D., Ph.D, Takeshi Kondo, M.D., Ph.D, Takao Koike, M.D., Ph.D

Blood (2004) 104 (11): 4112.

https://doi.org/10.1182/blood.V104.11.4112.4112

Published: 2004

Journal Articles

Comparison of sensitivity to ultraviolet B irradiation between human lymphocytes and hematopoietic stem cells

Hiroshi Azuma, Kenji Ikebuchi, Miki Yamaguchi, Hideaki Murahashi, Yuko Mogi, Norihiro Sato, Mitsuhiro Fujihara, Fumiya Hirayama, Hisami Ikeda

Blood (2000) 96 (7): 2632–2634.

https://doi.org/10.1182/blood.V96.7.2632

Published: 2000

Journal Articles

Different Adhesive Characteristics and VLA-4 Expression of CD34 + Progenitors in G 0 /G 1 Versus S+G 2 /M Phases of the Cell Cycle

Miki Yamaguchi, Kenji Ikebuchi, Fumiya Hirayama, Norihiro Sato, Yuko Mogi, Jun-ichi Ohkawara, Yoshihiro Yoshikawa, Ken-ichi Sawada, Takao Koike, Sadayoshi Sekiguchi

Blood (1998) 92 (3): 842–848.

https://doi.org/10.1182/blood.V92.3.842

Published: 1998

NARROW

FCGR3A-158V/F Polymorphism May Correlate with the Levels of Immunoglobulin in Patients with Non-Hodgkin’s Lymphoma after Rituximab Treatment as An Adjuvant to Autologous Stem Cell Transplantation.

DOCK180, a New Surrogate Marker to Distinguish CD34 Positive Acute Leukemia Cells from CD34 Positive Normal Hematopoietic Stem/Progenitor Cells.

Delayed Redistribution of CD27, CD40 and CD80 Positive B Cells and the Impaired In Vitro Immunoglobulin G Production in Patients with Non-Hodgkin Lymphoma Treated with Rituximab.

Absence of an IgD−/CD27+ Switched Memory B Cell Population with Persistent Hypogammaglobulinemia after Rituximab Administration as an Adjuvant Therapy after Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma.

A Clinical Trial of VVR Rate in Preoperative Autologous Blood Donation by Adults and Pediatrics Patients with or without IV Fluid Infusion.

Comparison of sensitivity to ultraviolet B irradiation between human lymphocytes and hematopoietic stem cells

Different Adhesive Characteristics and VLA-4 Expression of CD34 + Progenitors in G 0 /G 1 Versus S+G 2 /M Phases of the Cell Cycle

Email alerts

ASH Publications

American Society of Hematology

FCGR3A-158V/F Polymorphism May Correlate with the Levels of Immunoglobulin in Patients with Non-Hodgkin’s Lymphoma after Rituximab Treatment as An Adjuvant to Autologous Stem Cell Transplantation.

DOCK180, a New Surrogate Marker to Distinguish CD34 Positive Acute Leukemia Cells from CD34 Positive Normal Hematopoietic Stem/Progenitor Cells.

Delayed Redistribution of CD27, CD40 and CD80 Positive B Cells and the Impaired In Vitro Immunoglobulin G Production in Patients with Non-Hodgkin Lymphoma Treated with Rituximab.

Absence of an IgD−/CD27+ Switched Memory B Cell Population with Persistent Hypogammaglobulinemia after Rituximab Administration as an Adjuvant Therapy after Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma.

A Clinical Trial of VVR Rate in Preoperative Autologous Blood Donation by Adults and Pediatrics Patients with or without IV Fluid Infusion.

Comparison of sensitivity to ultraviolet B irradiation between human lymphocytes and hematopoietic stem cells

Different Adhesive Characteristics and VLA-4 Expression of CD34 + Progenitors in G 0 /G 1 Versus S+G 2 /M Phases of the Cell Cycle

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only